NCCN Collaborative Projects in Advanced Ovarian Cancer
Can Ovarian RADS MRI Identify Ovarian Cancer in Indeterminate Masses?
FDA Accepts sNDA for Niraparib in First-Line Maintenance Treatment of Ovarian Cancer
Fox Chase Researchers Receive Grant to Study High-Grade Serous Ovarian Cancer
Genetic Change May Distinguish Rare Benign Ovarian Tumors From Cancerous Tumors
Cyclophilin A: Potential Therapeutic Target in Serous Ovarian Cancer?
Can Cervical Scrapings From Pap Tests Detect Ovarian Cancer?
Maintenance Olaparib in Advanced Ovarian Cancer: PAOLA-1 Trial
Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care - Ovarian Cancer
Consensus or Controversy: Management of initial relapse of ovarian cancer — Eight investigators weigh in on their current approach based on genomic profiling
Oncology Grand Rounds: PARP Inhibitors in Ovarian Cancer
Cases from the Community: Clinical Investigators Provide Their Perspectives on Emerging Research and Actual Patients with Ovarian Cancer
The Ohio State University Comprehensive Cancer Center
Roswell Park Comprehensive Cancer Center
Vanderbilt-Ingram Cancer Center
ASCO: COVID-19 Medical Resources
Ovarian Cancer Research Fund Alliance
JNCCN: How To Manage Cancer Care During COVID-19 Pandemic